The changing landscape of treatment for acquired hemophilia A
Acquired hemophilia A (AHA) is a rare acquired autoimmune disorder caused by autoantibodies against coagulation factor VIII (FVIII), which cause a hemorrhagic diathesis, not rarely of severe degree. Standard treatment consists of bleeding control with bypassing agents (recombinant activated factor...
Spremljeno u:
| Glavni autori: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
PAGEPress Publications
2025-01-01
|
| Serija: | Bleeding, Thrombosis and Vascular Biology |
| Teme: | |
| Online pristup: | https://www.btvb.org/btvb/article/view/157 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|